Ka-Ching
It has been noticed by us at OSN lately that the coffers seem to have opened up again in Orthopedics and Spine. By our count, there have been 16 financing events since November 2009 with a few acquisitions to boot. Those 16 investments (ranging from angel rounds to Series D) have totaled a whopping $212.55 Million of fresh capital. Here is a list of the companies and recent investments:
2009 | ||
Spinal Modulation (Nov) | $27.4 Million | Series C |
Ortho Kinematics (Nov) | $3.5 Million | Series A |
Spinal Motion (Nov) | $27.4 Million | Series D |
Cardo Medical (Nov) | $6.2 Million | Private Placement |
Axiomed (Dec) | $6.4 Million | Series C |
2010 | ||
MiMedix Group (Jan) | $5.0 Million | Private Placement |
Salient Surgical (Jan) | $15.0 Million | Private Placement |
BioPoly (Jan) | $2.0 Million | Series A |
BioCeramic Therapeutics (Jan) | $1.9 Million | Series B |
OrthoAlign (Jan) | $5.2 Million | Series A |
Intra-Link Spine (Feb) | $0.75 Million | Grant |
Intrinsic Therapeutics (Feb) | $18.0 Million | Series B |
Carticept Medical (Mar) | $20.0 Million | Series B (With a Strategic, SonoSite) |
Spinal Restoration (Mar) | $20.0 Million | Series C |
Non-Linear Technologies (Mar) | $8.8 Million | Series B |
Let’s hear your thoughts. The economy, as it relates to Orthopedics and Spine, seems to have become stronger even with the looming healthcare reform debacle. Venture firms have shown a confidence in our industry again (not that it ever completely went away, it just went into hiding for a little while). This has to be good news, right?
Please feel free to leave your comments behind on this page. We are currently offering a less hostile place to let your voice be heard.